Quest diagnostics-agility running quantiferon qft-tb gold plus assay;13 incorrect assigned sample ids.Root cause: a sample barcode is not successfully scanned by the analyzer, the user ignores the on-screen sample tracking, also color coded led on the sample lanes and then scans new samples prior to clearing the rack.The agility is an open system used for automating elisa assays.Test samples are loaded in a sample rack, and the sample identification (sid) barcodes on the individual tubes are read and stored in the agility sid memory, to which assay results are then linked.Failed barcode scans are repeated until all samples in the rack have been successfully read.On investigation it was established that sample racks had been swapped without first cancelling the original sids.Agility users are trained that if a rack is to be aborted before all the sids have been successfully scanned, they must clear the sid memory for the rack by loading a completely empty rack; failure to do this can cause replacement sample assay results to be incorrectly linked to the original sample ids in the sid memory and no results will be reported against the replacement sample ids.According to the qft-tb gold elisa package insert (03/16), limitations:"results for qft testing must be used in conjunction with each individual's epidemiological history, current medical status, and results of other diagnostic evaluations"."the predictive value of a positive qft result in diagnosing m.Tuberculosis infection depends on the probability of infections, which is assessed by histological, epidemiological, diagnostic and other findings.A diagnosis of latent (b)(6) infection requires that (b)(6) must be excluded by medical evaluation including assessment of current medical and diagnostic disease as indicated.A negative result must be considered with the individual's medical and historical data relevant to probability of (b)(6) infection and potential risk of progression to (b)(6), particularly for individuals with impaired immune function.Negative predictive values are likely to be low for persons suspected to have (b)(6) disease and should not be relied on to exclude disease".
|